IMSTAR S.A.

Diomedes is a company that provides systems and services, specifically those that were previously offered by IMSTAR. The company has acquired IMSTAR's intellectual property and trademarks, and is now responsible for supplying its products. In essence, Diomedes is a continuation of IMSTAR's business, offering the same products and services that IMSTAR previously provided.

IMSTAR is a privately owned high-technology company based in Paris, France. At the top of their field, the IMSTAR experts design, manufacture and market automated digital imaging systems in cytopathology & cytogenetics, genetoxicity for drug safety & environmental biomonitoring , Life Sciences research and drug discovery.

The members of the team include key professionals, highly experienced in the different scientific fields: automated systems, biophysics, physics, applied mathematics, molecular genetics, neurosciences and cytology histology.

In 1985, IMSTAR was founded by Dr Françoise Soussaline, currently President, CEO & CSO, as a spin-off from the Biology Department of the French Atomic Energy Commission (Commissariat à l’Energie Atomique, CEA).

In 1997, IMSTAR launched the first automated, highly innovative and cost effective Image Cytometer based on Pathfinder™ Technology, associated with a number of Applied Analysis Software modules to facilitate and accelerate research.

Over the past 20 years, IMSTAR has aquired numerous patents and copyrights.

Over 1000 Pathfinder™ systems have been installed in the world to date, including Europe, North America and Asia.

IMSTAR offers complete vertical solutions for fully automated high-throughput cellular analysis in the fields of genotoxicity & environmental toxicity for compound screening & biomonitoring, cytopathology and drug discovery.